The novel neuronal nitric oxide synthase inhibi tors, 1-(2-trifluoromethylphenyl)imidazole (TRIM) and 7 -nitro indazole (7-NI), were used to investigate the role of nitric oxide in a model of transient focal cerebral ischemia in vivo, In halo thane-anesthetized rats, thc middle cerebral artery (MeA) was occluded for 2 hours using an intravascular thread and then reperfused for 22 hours before histologic evaluation. TRIM (10,20, or 50 mg/kg), 7-NI (60 mg/kg), TRIM (50 mg/kg) plus L-arginine (300 mg/kg), or L-arginine (300 mg/kg) alone was administered intraperitoneally, either at 5 or 90 minutes after MeA occlusion, Immediate administration (5 minutes after MCA occlusion) of TRIM produced a dose-related reduction in lesion size, which was reversed with L-arginine coadministra tion. Similarly, delayed administration of TRIM (90 minutes after MCA occlusion, 50 mg/kg) decreased total lesion volume by 48.4% ± 13.0% in comparison to a reduction of 39,3% ± Nitric oxide plays multiple roles in the pathophysiol ogy of focal cerebral ischemia (Dawson, 1994) . Focal cerebral ischemia in rats causes an immediate increase in the production of nitric oxide in cerebral tissue (Malinski et a!., 1993) and in the appearance of nitric oxide end products in plasma (Kumura et a!., 1994) . Experiments using conventional nitric oxide synthase (NOS) inhibi- 
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tors or nitric oxide donors have provided evidence that nitric oxide can act both as a neuroprotective and neu rotoxic agent in animal models of focal cerebral ischemia (for reviews see ladecola et aI., 1994; Dawson, 1994; Meldrum, 1996) . For example, administration of nitric oxide donors (sodium nitroprusside, 3-morpholino sydnonimine) or L-arginine reduces the size of the isch emic lesion induced by permanent middle cerebral artery (MeA) occlusion in rats (Zhang et aI., 1994; Iadecola, 1993, 1994; Morikawa et aI., 1 992a, 1994) . These data suggest that an increase in nitric oxide levels during cerebral ischemia may be beneficial in protecting against ischemic cell damage. This may be caused by several biologic actions of nitric oxide. Nitric oxide causes vasodilation, which results in an increase in ce rebral blood flow, thereby improving tissue perfusion and reducing ischemic cell damage (Morikawa et a!., 1992b (Morikawa et a!., , 1994 Zhang et aI., 1994) . Nitric oxide also in hibits platelet aggregation and leukocyte activation and adhesion, which may prevent additional thrombosis and minimize inflammation in the ischemic brain (Radomski et ai., 1987; Bath et ai., 199 1; Moncada et ai., 199 1) . Provisional data suggest that nitric oxide, administered as sodium nitroprusside, may attenuate platelet activation and improve cerebral blood flow in patients with acute stroke (Butterworth and Bath, 1996) . N-Methyl-o aspartate receptor activation can also be inhibited by ni tric oxide, possibly limiting glutamate excitotoxicity by a negative feedback mechanism (Manzoni et aI., 1992) .
In contrast to these potential beneficial effects, nitric oxide may itself be a mediator of neuronal destruction. Several studies using nonselective NOS inhibitors have shown that NOS inhibition may protect against cerebral ischemic damage in vivo (Nowicki et ai., 199 1; Nagafuji et aI., 1992; Buisson et aI., 1993; Ashwal et ai., 1993) . In vitro, nitric oxide has been shown to exacerbate ischemic cell damage by generating peroxynitrite (Radi et ai., 1991) , inhibiting iron-containing enzymes (Stadler et ai., 199 1) , and mediating glutamate neurotoxicity (Dawson et aI., 199 1) .
However, there are conflicting reports showing that nonselective NOS inhibitors have a variety of effects on lesion size after cerebral ischemia. Nitric oxide synthase inhibitors have been shown to reduce, increase, or have no effect on focal ischemic lesions depending on (1) the animal model, (2) the dosing regimens (time, dose, and route), and (3) the vasopressor action of the specific non selective NOS inhibitor used (Dawson, 1994; Iadecola et aI., 1994; . The develop ment of knockout mice deficient in the different isoforms of NOS (neuronal, endothelial, and inducible) has helped to clarify the role of nitric oxide in cerebral ischemia. Knockout mice with selective endothelial NOS deletion develop a larger infarct after MeA occlusion in compari son to wild-type controls (Huang et aI., 1996) . In con trast, neuronal NOS knockout mice demonstrate a reduc tion in the size of the infarct in comparison to wild-type controls after both permanent (Huang et ai., 1994) and transient MeA occlusion (Hara et ai., 1996) . Therefore, neuronal NOS may have a harmful role to play in isch emia but endothelial NOS may be protective.
Novel nitric oxide synthase inhibitors (e.g., 7-nitro in dazol [7 -NIL 1-(2-trifluoromethylpheny I) imidazole [TRIM] , and ARL 17477) that show a greater selectivity for certain NOS isoforms have recently been developed. 7-Nitro indazole is an inhibitor of the neuronal NOS in vitro and exhibits antinociceptive effects in vivo (Moore et aI., 1993a,b) . Although 7-NI also inhibits endothelial NOS in vitro, it is devoid of the vasopressor activity associated with existing nonselective NOS inhibitors such as L-� -nitro arginine methyl ester (Moore et aI., 1993a (Moore et aI., , 1993b Babbedge et aI., 1993; Rees et aI., 199 1) . Administration of 7-NI produced a 25% reduction in lesion volume in permanent MeA occlusion in rats, which was reversed by L-arginine coadministration (Yoshida et ai., 1994) . Similarly, ARL 17477, a potent and selective neuronal NOS inhibitor, decreased infarct volume after transient MeA occlusion in rats (Zhang et ai., 1996b) . ARL 17477 significantly inhibited cortical neuronal NOS activity by 80% in these rats, and this agent was also devoid of vasopressor activity. 1-(2-Trifluoromethylphenyl)imidazole has recently been de scribed as a potent inhibitor of both the neuronal and inducible NOS isoforms, but with poor activity on en dothelial NOS in vitro (Handy et ai., 1995) . This inhibi tor possesses antinociceptive activity but does not alter blood pressure in the mouse (Handy et aI., 1995 (Handy et aI., , 1996 .
In this study we have used TRIM and 7-NI to further investigate the role of nitric oxide in a reperfusion model of MeA occlusion in the rat. These agents are adminis tered after ischemia, which may be more relevant to the clinical situation. Our data indicate that TRIM and 7-NI are cerebroprotective when administered immediately af ter MeA occlusion; similarly, TRIM may also be effec tive when given 90 minutes after MeA occlusion.
MATERIALS AND METHODS
All experiments were carried out under U.K. Home Office regulations. Male Sprague-Dawley rats (300 to 350 g, Charles River, U.K.) were fasted overnight before surgery but allowed free access to water. The MCA was occluded for 2 hours using a method of intravascular occlusion (Koizumi et al., 1986; Zea Longa et al., 1989) . For occlusion of the MCA, an occluder thread was prepared. The tip of a 3-0 nylon Ethilon suture (Ethicon Ltd., U.K.) was rounded with sandpaper (PIOOO) and coated with a silicone compound to a diameter of 0.3 mm and a length of 3 mm. Anesthesia was induced with 3% halothane in oxygen and maintained with 1.75% to 2% halothane in oxy gen via a face mask in spontaneously breathing rats. The rectal body temperature was continuously monitored and maintained at 37.5°C throughout the surgery using a rectal probe and au tomated heat pad Ck-temp' unit, International Market supplies, U.K.). After a ventral midline incision in the neck, the right common carotid artery (CCA) was isolated and a cannula was inserted to collect blood samples for blood gas analysis imme diately before occlusion (Table 1 ). The right CCA was tempo rarily clamped, using a microsurgical clip, proximal to the bi furcation of the internal carotid artery and external carotid ar tery and a small incision was made in the CCA. The occluder thread was inserted, secured and then advanced through the CCA into the internal carotid artery to a distance of 18 to 20 mm (depending on body weight) from the internal carotid ar tery and external carotid artery bifurcation, until the suture blocked the origin of the MCA. The incision was closed and the rat was allowed to recover. On average the surgery was per formed within 25 minutes. After 2 hours of ischemia the intra luminal thread was removed under brief anesthesia (2% halo thane in oxygen), to allow reperfusion of the ischemic tissue. A small increase in rectal temperature was observed at this time point but there was no significant difference between treatment groups ( Table I) . Because the right CCA was ligated in this model, the ischemic tissue was reperfused via the circle of Willis through the contralateral carotid artery, basilar artery, and collateral circulation of the cerebral arteries.
After MCA occlusion, neurologic examination was per formed in the conscious rat at 1, 4, and 24 hours after MCA Delayed occlusion, using a 4-point scoring system (Bederson et aI., 1986b) . The neurologic deficit was assessed as follows: grade I, forelimb flexion; grade 2, decreased resistance to lateral push; or grade 3, gait disturbances leading to circling or walk ing to the left; grade 4, no neurologic deficit (Bederson et aI., 1986b) . Successful occlusion was demonstrated by an ani mal with a grade 3 deficit. All vehicle-or saline-treated rats exhibited left circling I hour (grade 3) after MCA occlusion ( Table I ).
Blood pressure measurements
In a separate group of animals the effect of saline, TRIM, or 7-Nl on arterial blood pressure was assessed. Surgery was per formed as described above for MCA occlusion, and blood pres sure was measured via the right carotid artery using a Mac Lab/ 8s (ADInstruments Ltd., U.K.) and recorded by an Apple Mac intosh computer (Powerbook 520c, Apple Ltd., U.K.). Blood pressure was monitored during ischemia and reperfusion in the anesthetized rat (maintenance, I % to 1.5% halothane). This group of animals were not allowed to recover from the anes thesia at the end of this experiment.
Determination of lesion size
Neuropathologic evaluation was performed at 24 hours after the induction of ischemia. The animals were anesthetized using 3% halothane and decapitated. The brains were removed and examined to confirm the position of the intravascular thread and the absence of subarachnoid hemorrhage or arterial pen etration with the thread. Five of 97 animals were excluded from the study because they demonstrated signs of subarachnoid hemorrhage after brain removal. The brains were sectioned coronally with a Jacobowitz rat brain slicer (Zivic-Miller Lab, Inc., Allison Park, PA U.S.A.) at 2-mm intervals and incubated for 30 minutes in 2% 2,3,5-triphenyltetrazolium chloride (TTC) at 37°C for vital staining (Bederson et aI., 1986a) . Then the sections were fixed by immersion in 10% formalin solution. The brain sections were scanned using a conventional, high resolution t1atbed scanner system (Agfa Ltd., U.K.) and lesion size was determined using an in-house semi automated image analysis system (Dispim software). Areas not stained red with TTC were considered lesioned. The total and lesion size (mm 2 ) was obtained for each coronal section. Lesion volume (mm 3 ) for each section was obtained by mUltiplying the lesion size by the slice thickness (2 mm). Total brain lesion volume was calculated as the sum of each slice volume.
Drug treatment
Animals were randomly assigned to drug or vehicle-treated groups. In group I, TRIM (10, 20, or 50 mg/kg), L-arginine (300 mg/kg), TRIM (50 mg/kg) plus L-arginine (300 mg/kg), or saline (\0 mLlkg) was injected intraperitoneally 5 minutes after MCA occlusion. In group 2, TRIM (50 mg/kg) or saline (10 mLlkg) was injected 90 minutes after MCA occlusion. In group 3, 7-NI (60 mg/kg) or the vehicle (0.25% methylcellulose, 10 mL/kg) was injected intraperitoneally 5 or 90 minutes after MCA occlusion. In group 4 (blood pressure experiments), sa line (10 mL/kg), TRIM (50 mg/kg), or 7-NI (60 mg/kg) was injected 5 minutes after MCA occlusion.
Materials and solutions
1-(2-Trifluoromethylphenyl)imidazole was obtained from Lancaster Synthesis Ltd., U.K. and dissolved in warm (37°C) physiologic saline (0.9%) at a concentration of 5 mg/mL. 7-Nitro indazole (Lancaster Synthesis Ltd.) was suspended in 0.25% wt/vol methylcellulose (400 cp, Sigma Ltd., U.K.) in HPLC-grade distilled water at 37°C, using sonication, at a con centration of 5 mg/mL. 2,3,5-Triphenyltetrazolium chloride was obtained from Sigma.
Statistical analysis
Data are presented as mean ± SD and were evaluated by analysis of variance and Tukey's test. Neurologic data were analyzed using Kruskal-Wallis followed by Dunn's procedure. Statistical significance was accepted at the P < 0.05 level.
RESULTS

Immediate or delayed NOS inhibition on lesion size
Immediate administration of TRIM (5 minutes after MCA occlusion) produced a dose-related inhibition of ischemic lesion size when measured at 24 hours after MCA occlusion (Fig, 1) , The highest dose of TRIM (50 mg/kg) significantly reduced total lesion volume by 39.3% ± lO.9% in comparison to saline-treated animals (Table 2) . Similarly, delayed administration of TRIM (50 mg/kg, 90 minutes) significantly reduced the total lesion K. 1. ESCOIT ET AL. size by 48.4% ± 13.0%. There was no significant differ ence in the reduction in lesion size between immediate or delayed TRIM-treated (50 mg/kg) groups (Table 2) . Also, immediate (5 minutes) administration of TRIM (50 mg/kg) produced a significant (P < 0.05) improvement in the neurologic score at I and 24 hours after MeA oc clusion, in comparison to saline-treated animals ( Table  I) . The neurologic score (1 or 24 hours after MeA oc clusion) after delayed administration of TRIM was not significantly (P > 0.05) different from the appropriate saline-treated group.
Administration of 7-NI (60 mg/kg, intraperitoneally) produced a significant 38.5% ± 13.7% reduction in total lesion volume when given immediately (5 minutes) after MeA occlusion, but no significant (P > 0.05) cerebro protection was observed on delayed administration (90 minutes) (Table 2 and Fig. 2 ). Neither immediate nor delayed administration of 7-NI had any significant (P > 0.05) effect on neurologic score in comparison to ve hicle-treated group (Table I) .
Striatal and cortical lesion volumes were analyzed to investigate further the area of the ischemic lesion that was affected by NOS inhibition. Immediate (5 minutes) admin istration of either TRIM or 7-NI reduced the lesion volume in both the striatum and the cortex ( Table 2 ). The reduction in the size of the cortical lesion was, however, more pro nounced in comparison to the striatal lesion. Delayed ad ministration of TRIM, but not 7-NI, also decreased the size of the striatal and cortical lesion (Table 2) .
L-Arginine reversal of TRIM cerebroprotection
Immediate administration (5 minutes) of L-arginine (300 mg/kg) alone or coadministration of L-arginine with TRIM (50 mg/kg) had no significant (P > 0.05) effect on the total lesion volume or the neurologic score (l or 24 hours after MeA occlusion), in comparison to saline treated animals ( Fig. 3; Table 1 ). Therefore, L-arginine significantly reversed the cerebroprotective effect of TRIM (Fig. 3) .
Effect of NOS inhibition on blood pressure
Middle cerebral artery occlusion caused a transient reduction in mean arterial blood pressure, which returned Values are mean ± SD. to baseline levels before intraperitoneal injections at 5 minutes after MCA occlusion. Neither saline, TRIM, nor 7-NI had any significant effect on blood pressure during either the ischemic or reperfusion periods after MCA occlusion (Table 3) . These results are in keeping with previous studies in normal animals, which have shown no significant (P > 0.05) change in blood pressure on administration of TRIM or 7-NI (Handy et a!., 1995; Moore et ai., 1993a) .
DISCUSSION
This study demonstrates that inhibition of NOS with either TRIM or 7-NI reduces the size of the ischemic lesion measured 24 hours after transient focal cerebral ischemia. Immediate administration of TRIM (5 minutes after occlusion) produced a dose-related inhibition of the lesion size after reversible MCA occlusion. Delayed ad ministration (90 minutes after occlusion, i.e., 30 minutes before reperfusion) of the highest dose of TRIM (50 mg/kg) also reduced the size of the ischemic lesion. The observation that TRIM is protective even after delayed treatment is similar to a previous study using the novel selective neuronal NOS inhibitor, ARL 17477, which decreased infarct volume after transient MCA occlusion in rats when administered at the time of reperfusion ( 120 minutes after occlusion; Zhang et a!., 1996h). These re sults show that there is a modest therapeutic time win dow for NOS inhibition in reversible focal cerebral isch emia and confirm previous findings that suggest a detri mental role for neuron ally synthesized nitric oxide in the acute stages of focal cerebral ischemia. Immediate ad- Bar graph shows the total lesion volume (mm3), and values are mean ± SD. Saline (10 mUkg, n = 11), TRIM (50 mg/kg, n = 9), L-arginine (300 mg/kg, n = 9), or TRIM (50 mg/kg) plus L-arginine (300 mg/kg, n = 9) was administered 5 minutes after MeA occlu sion. Administration of TRIM significantly reduced the total lesion volume in comparison with the saline-treated group (*P < 0.05).
L-Arginine alone and L-arginine plus TRIM were not significantly different from saline-treated groups (analysis of variance and Tukey's test). ministration of TRIM also partially reduces the deficits in motor function observed I and 24 hours after transient MCA occlusion, which is described as a decrease in the neurologic score in comparison to saline-treated groups. These results provide evidence that TRIM not only pro tects against the physical ischemic damage, indicated by TTC staining, but also reduces the deficit in neurologic function observed after transient focal cerebral ischemia. More recently, our group has confirmed the cerebropro tective effect of immediate administration of TRIM us ing magnetic resonance imaging (Haga et a!., 1997) .
Immediate administration of 7 -NI (5 minutes after MCA occlusion) decreased the total lesion volume at a dose that does not alter blood pressure and that has been shown previously to reduce neuronal NOS activity by 50% in the cerebral cortex . The cerebroprotective effect of 7-NI is similar to a previous report in which 7-NI (50 mg/kg) was shown to inhibit lesion volume by 25% after permanent MCA occlusion, an effect that was reversed by L-arginine (Yoshida et ai., 1994) . In our study, 7-NI reduces both striatal and cor tical lesion sizes, which confirms findings using the per manent MCA occlusion model . The apparently greater effect of 7-NI reported here in the reversible model (38% reduction) compared with 25% in the permanent model of MCA occlusion, if significant, could reflect the difference in the severity of the isch emic time periods or the slightly higher dose of 7-NI used in our study. In contrast to the cerebroprotective effect of TRIM (administered 90 minutes after occlu sion), delayed administration of 7-NI showed no signifi cant effect on the lesion size. It is unclear why TRIM, but not 7-NI, was protective when administered 90 minutes after occlusion, especially because 7-NI is a more potent nNOS inhibitor than TRIM in vitro (Handy et aI., 1996) .
One possibility is that TRIM is more soluble than 7-NI and thus may have a higher bioavailability than 7-NI.
Interestingly, L-arginine alone had no effect on lesion size. This finding matches other reports that L-arginine does not improve histologic outcome in rats subjected to either a distal occlusion of the MCA using photothrom botic techniques (Prado et aI., 1996) or permanent MCA occlusion (Buisson et aI., 1993; Iadecola et aI., 1995a) . In contrast, delayed administration of L-arginine at 24, 48, and 72 hours after MCA occlusion enlarged the in farct by 29% after transient focal cerebral ischemia (Zhang et aI., 1996a) . There are however several reports that L-arginine reduces ischemic lesion volume after per manent MCA occlusion in spontaneously hypertensive rats (Morikawa et aI., 1992a; Hamberg et aI., 1993) and in normotensive Sprague-Dawley rats (Morikawa et aI., 1994) . L-Arginine also increases cerebral blood flow in ischemic (Hamberg et aI., 1993; Morikawa et aI., 1994) and nonischemic rats (Dalkara et ai., 1994; Prado et aI., 1996) . The protective effect of L-arginine is thought to be mediated by nitric oxide-dependent cerebrovascular di lation increasing blood flow to the penumbral region of the ischemic lesion (Morikawa et aI., 1994; Dalkara et aI., 1994) . These studies, which demonstrated neuropro tection with L-arginine, used mUltiple dosing regimes or intravenous infusions (Morikawa et aI., I 992a, 1994) . It is likely that L-arginine did not have any protective effect in our study because it was given as a single intraperi toneal injection after MCA occlusion.
It has been suggested that the mechanism of action of both TRIM and 7-NI is through the inhibition of NOS, preventing the conversion of L-arginine to nitric oxide (Handy et aI., 1995; Moore et aI., 1993a; Yoshida et aI., 1994) . Neither TRIM or 7-NI had any effect on arterial blood pressure at the highest doses used, which is con sistent with other studies in the mouse and rat (Handy et aI., 1995; Moore et aI., 1993a Moore et aI., , 1993b Rees et aI., 1991; Smith et ai., 1996) . These results suggest that endothelial NOS is not inhibited to any significant extent during this transient model of focal cerebral ischemia. Also, coad ministration of L-arginine with TRIM reversed the pro tective effect observed with TRIM alone, thereby sug gesting that the mechanism of action of TRIM is through the inhibition of NOS. Direct measurement of NOS ac tivity in vivo would help to confirm the mechanism of neuroprotection by TRIM.
Slight hyperthermia, which could contribute to the de velopment of the ischemic lesion, was observed at the time of reperfusion, and previously a reduction in body temperature has been shown to be neuroprotective (Chen et ai., 1992) . However, TRIM and 7-NI are unlikely to be cerebroprotective as a result of a reduction in body tem perature because at the time of reperfusion there was no J Cereh Blood Flow Metah. Vol. 18. No. 3. 1998 temperature difference between control and drug-treated groups. Similarly, 24 hours after MCA occlusion no dif ference in body temperature was observed (unpublished communication) . Also, neither agent had any effect on systemic blood pressure on intraperitoneal administra tion. Therefore, we can conclude that there should not be any major change in body temperature because of any potential hemodynamic effects of TRIM or 7-NI.
Although both TRIM and 7-NI have been shown to be relatively selective inhibitors of neuronal NOS, a pos sible effect on inducible NOS should be considered (Moore et aI., 1993a (Moore et aI., , 1993b Babbedge et aI., 1993; Handy et aI., 1995) . Expression of brain inducible NOS mRNA, however, begins at 12 hours and peaks 48 hours after MCA occlusion, and inducible NOS catalytic ac tivity is observed only 48 hours after ischemia (Iadecola et aI., 1995b) . Therefore, it is unlikely that TRIM or 7-NI alters inducible NOS activity, because the protocol used in our study measured lesion size only 24 hours after occlusion. Also, both agents were administered in the acute stages «2 hours) of ischemic cell damage, before expression of the inducible NOS protein.
In conclusion, inhibition of NOS with TRIM or 7-NI elicited protection against ischemic cell damage after transient focal cerebral ischemia in rats. These results confirm previous observations that neuronally derived nitric oxide is detrimental in the early stages of transient focal cerebral ischemia in vivo.
